PRISM BioLab Co.,LTD
206A.T · JPX
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | ¥6,137 | ¥12,835 | ¥20,117 | ¥20,117 |
| - Cash | ¥2,916 | ¥4,392 | ¥1,134 | ¥1,688 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥3,222 | ¥8,443 | ¥18,983 | ¥18,429 |
| Revenue | ¥677 | ¥306 | ¥113 | ¥554 |
| % Growth | 121.6% | 170.6% | -79.6% | – |
| Gross Profit | ¥270 | ¥161 | ¥80 | ¥535 |
| % Margin | 39.8% | 52.5% | 71.1% | 96.5% |
| EBITDA | -¥831 | -¥1,048 | -¥488 | ¥68 |
| % Margin | -122.7% | -343% | -432.3% | 12.2% |
| Net Income | -¥834 | -¥1,050 | -¥527 | ¥73 |
| % Margin | -123.1% | -343.4% | -466.6% | 13.2% |
| EPS Diluted | -22.82 | -33.53 | -19.09 | 2.06 |
| % Growth | 31.9% | -75.6% | -1,026.7% | – |
| Operating Cash Flow | -¥1,468 | ¥150 | -¥514 | ¥103 |
| Capital Expenditures | -¥65 | -¥212 | -¥35 | -¥6 |
| Free Cash Flow | -¥1,533 | -¥62 | -¥548 | ¥97 |